Study guide

11.4 Salivary Gland Disease

MFDS Part 1 Membership of the Faculty of Dental Surgery

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

Current Exam Facts How to Use This Guide Eligibility, Booking & the MFDS Pathway

2 Basic Sciences, History Taking & Clinical Assessment

1.1 Head & Neck Anatomy and Underpinning Basic Sciences 1.2 History Taking, Communication & Clinical Examination 1.3 Special Tests, Investigations & Diagnostic Accuracy 1.4 Differential Diagnosis, Triage & When to Biopsy 1.5 Dental Anomalies & Developmental Conditions

3 Cariology, Operative Dentistry & Endodontics

2.1 Cariology & Caries Diagnosis 2.2 Caries Management & Prevention 2.3 Operative Dentistry & Cavity Preparation 2.4 Endodontics 2.5 Tooth Surface Loss & Tooth Discolouration

4 Periodontology & Prosthodontics

3.1 Periodontology 3.2 Fixed Prosthodontics 3.3 Removable Prosthodontics 3.4 Occlusion & Occlusal Assessment

5 Paediatric Dentistry, Orthodontics & Dental Trauma

4.1 Paediatric Dentistry 4.2 Orthodontics 4.3 Dental Trauma 4.4 Orthodontic Assessment, Indices & Referral 4.5 Impacted Teeth & Radiographic Localisation

6 Oral Surgery, Treatment Planning & Prevention

5.1 Oral Surgery & Extractions 5.2 Treatment Planning & Patient Management 5.3 Prevention & Health Promotion

7 Cardiovascular, Respiratory & Endocrine Disease

6.1 Cardiovascular Disease 6.2 Respiratory Disease 6.3 Endocrine Disease & Diabetes 6.4 Bleeding Disorders & Anticoagulation

8 Haematology, Infection & the Medically Compromised Patient

7.1 Haematology 7.2 Infectious Disease 7.3 The Medically Compromised Patient 7.4 Neurological & Gastrointestinal Disease

9 Medical Emergencies in Dental Practice

8.1 Medical Emergencies & Resuscitation 8.2 Anaphylaxis & Acute Allergy 8.3 Emergency Drugs & the Resuscitation Kit

10 Special Care Dentistry, Mental Health & Anxiety Management

9.1 Special Care Dentistry & Patients with Disability 9.2 Mental Health & Behavioural Science 9.3 Dental Anxiety & Behaviour Management

11 Oral Medicine — Mucosal Disease & Orofacial Pain

10.1 Oral Mucosal Disease & Lichen Planus 10.2 Vesiculobullous & Ulcerative Disorders 10.3 Candidiasis & Fungal Infections 10.4 Orofacial Pain & Neuropathic Disorders

12 Oral Pathology — Lesions, Cysts, Tumours & Salivary Glands

11.1 Premalignant Lesions & Oral Cancer 11.2 Odontogenic Cysts 11.3 Odontogenic & Non-Odontogenic Tumours 11.4 Salivary Gland Disease

13 Pharmacology — Local Anaesthesia, Analgesia & Sedation

12.1 Local Anaesthesia 12.2 Analgesics & NSAIDs 12.3 Conscious Sedation

14 Pharmacology — Antimicrobials, Prescribing & Drug Interactions

13.1 Antimicrobials & Antibiotic Stewardship 13.2 Prescribing & Drug Interactions

15 Dental Materials

14.1 Properties & Testing of Dental Materials 14.2 Amalgam & Metal Restorations 14.3 Composite Resin & Adhesive Dentistry 14.4 Impression Materials, Cements & Other Materials

16 Microbiology, Infection Control & Radiology

15.1 Oral Microbiology & Infection Control 15.2 Dental Radiology & Imaging 15.3 Radiation Protection

17 Law, Ethics, Professionalism & Evidence-Based Dentistry

16.1 Consent & Confidentiality 16.2 GDC Standards & Professionalism 16.3 Safeguarding & Duty of Candour 16.4 Evidence-Based Dentistry & Research Methods 16.5 Records, Information Governance & Regulation 16.6 Communication, Teamworking, Human Factors & Raising Concerns

18 Statistics, Dental Public Health, Critical Appraisal & Exam Strategy

17.1 Statistics & Critical Appraisal 17.2 Dental Public Health & Epidemiology 17.3 SBA Technique & Exam Strategy 17.4 Final Review & Key Points

11.4 Salivary Gland Disease

Key Takeaways Explain This Topic AI

A lower-lip bluish fluctuant swelling in a teenager with no epithelial lining histologically is a mucous extravasation mucocele — the most common salivary lesion; treat by excising the cyst and its associated minor gland

Sialolithiasis causes mealtime-related swelling that resolves between meals; around 80% of stones form in the submandibular duct (Wharton's) because of mucinous alkaline, anti-gravity, calcium-rich saliva

Pleomorphic adenoma is the most common salivary tumour (~80% in the parotid); it has a fragile capsule prone to rupture and spillage, so it is treated by superficial parotidectomy with facial nerve preservation rather than enucleation

Adenoid cystic carcinoma shows the cribriform 'swiss-cheese' pattern and has the hallmark of perineural invasion with skip lesions along nerves — slow but with late recurrence and lung metastases; long-term prognosis is poor

Sjögren's syndrome (anti-Ro/SSA and anti-La/SSB; minor gland focus score ≥1) carries a markedly increased risk of MALT lymphoma — persistent unilateral parotid enlargement or new firmness warrants urgent investigation

Last updated: August 2026

Mucocele and Ranula

Mucocele is the most common salivary gland lesion. Two types:

Mucous extravasation 'cyst' (most common) — saliva pools in connective tissue after trauma to a minor gland duct; no epithelial lining . Classical site: lower lip . Patients: children/young adults; bluish translucent fluctuant swelling that fluctuates in size; not acutely tender.

Mucous retention cyst — true epithelial-lined cavity, less common, often older patients.

Management: excision of the cyst and the associated minor gland (recurrence occurs if the feeding gland is left).

Ranula — a mucocele in the floor of mouth above the mylohyoid; appears as a bluish cross-shaped swelling. Plunging ranula herniates through the mylohyoid to present as a neck swelling crossing the submental and submandibular regions. Management: marsupialisation, excision of the sublingual gland, or sclerotherapy for plunging ranula.

Acute Bacterial Sialadenitis

Most often affects the parotid and submandibular glands.

Risk factors: dehydration, reduced flow (post-operative, elderly, radiotherapy), medications with anticholinergic effect, Sjögren's.

Ascending ductal infection : Staphylococcus aureus , Streptococcus viridans , occasionally anaerobes.

Presentation: painful, swollen, tender gland; pus from the duct orifice on massage; fever; malaise.

Management: hydration, warm massage, sialogogues, antibiotics (flucloxacillin first-line; clindamycin if penicillin-allergic). Most settle within days; gland abscess requires surgical drainage.

Sialolithiasis

Formation of a salivary stone (calculus).

Around 80% occur in the submandibular gland (Wharton's duct) , ~20% in the parotid (Stensen's duct).

Why the submandibular gland? mucinous alkaline saliva, longer duct, anti-gravity flow, higher calcium and phosphate content.

Presentation: painful swelling at mealtimes that resolves between meals; can become chronic/recurrent.

Radio-opacity: around 80% of submandibular stones are radio-opaque (vs ~40–60% of parotid stones) on plain film.

Imaging: occlusal radiograph for anterior submandibular stones; CBCT; ultrasound; sialography is largely superseded by sialoendoscopy.

Management:

Distal stones — removal via the duct orifice (bimanual massage, intraoral incision).

Proximal / intraglandular stones — interventional sialoendoscopy first-line where available; gland excision if recurrent or refractory.

Salivary Gland Tumours

Tumour Type Key features

Pleomorphic adenoma Benign 'mixed' Most common; ~80% in parotid; myoepithelial cells + chondroid/myxoid stroma; capsule prone to rupture; recurs if spilled; small malignant transformation risk (carcinoma ex-pleomorphic adenoma)

Warthin's tumour Benign Papillary cystadenoma lymphomatosum; parotid tail; smokers; male predominance; bilateral / multifocal in ~5–10%; lymphoid stroma with cystic spaces and papillary projections

Mucoepidermoid carcinoma Malignant Most common salivary malignancy; mucous, epidermoid, and intermediate cells; low/intermediate/high grade; parotid most common; TNM stage drives prognosis

Adenoid cystic carcinoma Malignant Perineural invasion ; cribriform 'swiss cheese' pattern; parotid and minor glands; slow indolent course; late local recurrence and lung metastases ; poor long-term prognosis

Pleomorphic Adenoma

Most common salivary gland tumour (~60% of all salivary neoplasms).

~80% arise in the parotid (usually superficial lobe); also submandibular and minor glands (palate).

Histology: myoepithelial cells + stromal elements (chondroid, myxoid) — 'mixed tumour'.

Well-encapsulated; recurs if ruptured/spilled — strict superficial parotidectomy with facial nerve preservation is the management, not enucleation.

Small risk of malignant transformation (carcinoma ex-pleomorphic adenoma) — sudden rapid growth, pain, or facial nerve palsy in a long-standing parotid mass is a red flag.

Warthin's Tumour

2nd most common benign parotid tumour.

Parotid tail ; smokers; male predominance; bilateral in ~5–10% of cases.

Cystic spaces with papillary projections and a lymphoid stroma.

Management: superficial parotidectomy; benign. May be observed if small and asymptomatic in selected patients.

Mucoepidermoid Carcinoma

Most common salivary malignancy in both adults and children.

Parotid is the most common site.

Mucous, epidermoid, and intermediate cells; grading (low/intermediate/high) drives prognosis.

TNM staging; surgery ± radiotherapy.

Adenoid Cystic Carcinoma

Cribriform 'swiss cheese' pattern (most characteristic); also tubular and solid (worst prognosis).

Perineural invasion is the hallmark — skip lesions along nerves; facial nerve involvement common in parotid tumours, causing pain or weakness.

Slow indolent course but late local recurrence and distant metastases (lung > bone); long-term prognosis is poor despite indolence.

Surgery + radiotherapy; not chemotherapy responsive.

Sjögren's Syndrome

Primary Sjögren's : xerostomia + keratoconjunctivitis sicca without another connective tissue disease. Autoimmune lymphocytic destruction of exocrine glands. Strongly associated with anti-Ro/SSA and anti-La/SSB antibodies (anti-La/SSB more specific).

Secondary Sjögren's : with rheumatoid arthritis, SLE, or other connective tissue disease.

Investigations: Schirmer's test (<5 mm in 5 min), unstimulated whole saliva flow, serology (anti-Ro/SSA, anti-La/SSB, ANA, rheumatoid factor), and minor salivary gland biopsy (focus score ≥1 per 4 mm²).

Increased risk of lymphoma — overall lifetime risk around 5–10%, with a markedly increased relative risk (~16–44×) of B-cell lymphoma, most often MALT lymphoma . Watch for persistent unilateral parotid enlargement, new firmness or nodularity, or rising immunoglobulin levels — investigate with imaging and biopsy.

Xerostomia and Sialorrhoea

Xerostomia (dry mouth) — causes and management:

Causes Management

Drugs (antidepressants, anticholinergics, antihistamines, antihypertensives) Salivary stimulants: sugar-free gum/xylitol lozenges

  • Radiotherapy (head and neck) Saliva substitutes; water sips
  • Sjögren's syndrome Pilocarpine or cevimeline if residual gland function remains

Diabetes, anxiety, dehydration Preventive dental care: high-fluoride toothpaste (5000 ppm), fluoride varnish, recall

Sialorrhoea (excess saliva) — cerebral palsy, Parkinson's disease, developmental disorders, teething, pregnancy. Management: anticholinergics (hyoscine), botulinum toxin injection into the major salivary glands, or surgical duct repositioning in selected cases.

MFDS red flag: A parotid mass with new facial nerve weakness is not a benign pleomorphic adenoma until proven otherwise — the differential includes adenoid cystic carcinoma, carcinoma ex-pleomorphic adenoma, and primary salivary malignancy. Refer urgently to a head and neck MDT.